News
Apply Today: Avalere Health Advisory Pro Bono Grant
Avalere Health Advisory is accepting applications for its pro bono grant program, awarding donated or deeply discounted consulting services for projects dedicated to improving healthcare delivery, access, and outcomes.
Arthritis Foundation To Receive Pro Bono Services From Avalere Health Advisory
Avalere Health launches a new pro bono initiative, offering free Advisory services to non-profit organizations looking to reach EVERY PATIENT POSSIBLE. The company is now accepting applications for Fall 2025.
Research on Opioid Use Reveals States, Local Governments Spend $94 Billion Annually
“The Cost of Addiction: Opioid Use Disorder in the U.S.” is the first-of-its-kind study that reveals state and local governments shoulder a significant financial burden on taxpayers, businesses, and communities.
CMS Deputy Group Director Mark Newsom Joins Avalere Health’s Advisory Team
Mark Newsom will play a strategic role in helping clients understand and prepare for the potential impact the current administration will have on their business strategies.
Developing winning supplemental benefits packages
Avalere Health and the Managed Care Resource Alliance discuss how health plan leaders can develop benefit packages that resonate with various demographics.
PharmaTimes article: Overcoming barriers to care using AI
Artificial intelligence (AI) can be used to optimize home-based care, easing provider burden in sites that struggle with capacity.
Avalere Is Awarded Accelerated Access to Medicare Claims Data
A new agreement with CMS Virtual Data Research Center will support analysis of more recent Part A, B, and D claims with a focus on the impact of COVID-19.
NORD Summit Reveals 2025 Rare Disease Priorities
Avalere attendees of the National Organization of Rare Disorders (NORD) Breakthrough Summit shared a recap of themes from the conference in MedAd News.
Avalere Covered in Nephrology News
With nearly 4,000 posters presented at ASN’s annual conference, Avalere’s study of post-COVID home dialysis stands apart with a feature in Nephrology News.
Avalere Published in PM360: Research that Reflects Reality
For researchers developing new medicines and therapies, real-world data gives them an understanding of patients’ actual experiences outside of clinical trials.
Avalere Industry Outlook Report Wins 2024 Design Award
Graphic Design USA, a publication for graphic design professionals, recognized Avalere's annual report in its Inhouse Design Awards Competition.
Health Policy Veteran Emily Donaldson Joins Avalere
Emily Donaldson brings 15 years of experience supporting pharmaceutical manufacturers and health plans, focused on insurance markets and state healthcare policy.
Rethinking Evidence Strategy in HEOR Budget Planning
Avalere experts in health economics and outcomes research (HEOR) identify four elements of evidence strategy development in Pharma Focus America.
Clinical Trial Designs for Rare and Ultra-Rare Disease
In Med Ad News, Mariia Saldova shares innovative ways to overcome the challenges of planning and executing clinical trials in small patient populations
The FDA’s Final Rule on Laboratory-Developed Tests (LDTs)
Laura Housman’s article in the July issue of MedTech Intelligence explores the potential impact of the FDA’s rule to overhaul its regulation of LDTs.
An Access Path for Digital Therapeutics
Based on Brigit Kyei-Baffour’s panel presentation at BIO 2024, Med Ad News published a summary of the insights from participants.
Avalere Welcomes Industry Veteran Ashley Flint to Policy Team
Ashley Flint brings 12 years of policy experience in the life sciences industry, with deep knowledge of prescription drug pricing, access, and reimbursement.
Establishing Value in an Uncertain and Dynamic Landscape
On June 5, The Evidence Base published an article entitled, “Navigating uncertainty: redefining healthcare value in an evolving healthcare landscape,” covering key topics from Avalere’s ISPOR theater session.
Sarah Alwardt Brings Data and Technology to the Forefront in Dual Role as President of Avalere and U.S. Policy, Access, Value and Evidence at Avalere Health
Avalere is pleased to announce Sarah Alwardt, PhD as its new President.
New Roles for Avalere Senior Leadership
Avalere is pleased to announce the promotion of three leaders in its Evidence & Strategy and Market Access practices.